DAFTAR PUSTAK2

4
DAFTAR PUSTAKA 1. Helena M, Tiago K, João S et al. Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet. 2010; 11: 40. 2. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. Jan 2003;2(1):43-53. 3. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. Oct 16 2007;116(16):e391-413. 4. Yock-Corrales A, Mackay MT, Mosley I, Maixner W, Babl FE. Acute childhood arterial ischemic and hemorrhagic stroke in the emergency department. Ann Emerg Med. Aug 2011;58(2):156-63. 5. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. May 10 2008;371(9624):1612-23 6. Global Burden of Stroke. The Atlas of Heart Disease and Stroke. MacKay J, Mensah GA. World Health Organization. 7. Wintzen AR, de Jonge H, Loeliger EA, Bots GT: The risk of intracerebral hemorrhage during oral

description

contoh dapus

Transcript of DAFTAR PUSTAK2

Page 1: DAFTAR PUSTAK2

DAFTAR PUSTAKA

1. Helena M, Tiago K, João S et al. Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet. 2010; 11: 40.

2. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. Jan 2003;2(1):43-53.

3. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. Oct 16 2007;116(16):e391-413.

4. Yock-Corrales A, Mackay MT, Mosley I, Maixner W, Babl FE. Acute

childhood arterial ischemic and hemorrhagic stroke in the emergency department. Ann Emerg Med. Aug 2011;58(2):156-63.

5. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. May 10 2008;371(9624):1612-23

6. Global Burden of Stroke. The Atlas of Heart Disease and Stroke. MacKay J, Mensah GA. World Health Organization.

7. Wintzen AR, de Jonge H, Loeliger EA, Bots GT: The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol 1984; 16: 553–558.

8. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM: The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004; 164: 880–884.

9. Kelompok Studi Stroke Perhimpunan Dokter Spesialis Saraf Indonesia.Guideline Stroke 2007. Edisi Revisi. Perhimpunan Dokter Spesialis Saraf Indonesia: Jakarta, 2007.

10. Nasissi, Denise. Hemorrhagic Stroke Emedicine. Medscape, 2010. Available at: http://emedicine.medscape.com/article/793821-overview. [Tanggal: 10 Maret 2015]

11. Price, Sylvia A. Patofisiologi Konsep Klinis Proses-proses Penyakit ed.6.EGC, Jakarta. 2006

Page 2: DAFTAR PUSTAK2

12. Sjahrir, Hasan. Stroke Iskemik. Yandira Agung: Medan, 2003

13. Ropper AH, Brown RH. Adams dan Victor’s Principles of Neurology. Edisi 8. BAB 4. Major Categories of Neurological Disease: Cerebrovascular Disease. McGraw Hill: New York.2005

14. Sotirios AT,. Differential Diagnosis in Neurology and Neurosurgery.New York. Thieme Stuttgart. 2000.

15. Silbernagl, S., Florian Lang. Teks & Atlas Berwarna Patofisiologi. EGC: Jakarta, 2007.

16. MERCK, 2007. Hemorrhagic Stroke. Available at: http://www.merck.com/mmhe/sec06/ch086/ch086d.html. [Tanggal: 10 Maret 2015]

17. Samino. Perjalanan Penyakit Peredaran Darah Otak. FK UI/RSCM, 2006. Diunduh dari: http://www.kalbe.co.id/files/cdk/files/13PerjalananPenyakit PeredaranDarahOtak021.pdf/13PerjalananPenyakitPeredaranDarahOtak021.html [Tanggal: 10 Maret 2015]

18. Mesiano, Taufik. Perdarahan Subarakhnoid Traumatik. FK UI/RSCM, 2007. Diunduh dari: http://images.omynenny.multiply.multiplycontent.com/ attachment/0/R@uuzQoKCrsAAFbxtPE1/SAH%20traumatik%20Neurona%20by%20Taufik%20M.doc?nmid=88307927 [Tanggal: 10 Maret 2015]

19. Baker, R. I.; Coughlin, P. B.; Gallus, A. S.; Harper, P. L.; Salem, H. H.; Wood, E. M.; Warfarin Reversal Consensus, G. Warfarin reversal: Consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. The Medical journal of Australia 2014. 181 (9): 492–497.

20. Palareti, G. A guide to oral anticoagulant therapy. Italian Federation of Anticoagulation Clinics. Haemostasis. 28 Suppl 1998. 1: 1–46.

21.  Franchini, Massimo, and Giuseppe Lippi. Prothrombin complex concentrates: an update. Blood Transfusion 8.3 (2010): 149.

22. Erber WN, Perry DJ. Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol 2006; 19: 97-112.

23. Makris M, Greaves M, Phillips WS, et al. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77: 477-80.

Page 3: DAFTAR PUSTAK2

24. Cartmill M, Dolan G, Byrne JL, Byrne PO. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 2000; 14:458-61.